Caffeoyltryptophan

Caffeoyltryptophan is a competitive PTP1B inhibitor, with an IC50 of 16.99 μM. Caffeoyltryptophan can also inhibit α-glucosidase, linoleic acid peroxidation and haemolysis. Caffeoyltryptophan can be used for the research of type 2 diabetes[1].

Product Specifications

CAS Number

[109163-69-1]

UNSPSC

12352005

Target

Glycosidase; Phosphatase

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/caffeoyltryptophan.html

Purity

98.06

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

OC(C=C1/C=C/C(N[C@H](C(O)=O)CC2=CNC3=CC=CC=C23)=O)=C(C=C1)O

Molecular Formula

C20H18N2O5

Molecular Weight

366.37

References & Citations

[1]Ha MT, et, al. PTP1B and α-glucosidase inhibitory activities of the chemical constituents from Hedera rhombea fruits: Kinetic analysis and molecular docking simulation. Phytochemistry. 2022 May:197:113100. |[2]Ohnishi M, et, al. Inhibition in vitro linoleic acid peroxidation and haemolysis by caffeoyltryptophan. Phytochemistry. 1998 Apr;47 (7) :1215-8.